# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company developing an innovative drug delivery technology d...
Quince Therapeutics (NASDAQ:QNCX) reported quarterly losses of $(0.21) per share. This is a 61.54 percent decrease over losses ...
Strong Cash Position Expected to Support Meaningful Clinical Milestone Reported $75.1 million in cash, cash equivalents, and...
-SEC Filing
The Dow Jones closed higher by over 60 points on Thursday. When insiders purchase or sell shares, it indicates their confidence...
The Dow Jones closed higher by around 300 points on Friday. When insiders purchase or sell shares, it indicates their confidenc...
Gainers RVL Pharmaceuticals plc (NASDAQ: RVLP) shares rose 181.8% to $0.2201 in pre-market trading.
The Dow Jones closed higher by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence ...